Treace Medical Concepts (TMCI) Operating Leases (2022 - 2026)

Treace Medical Concepts (TMCI) has reported Operating Leases for 5 consecutive years, with $13.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Leases fell 2.57% year-over-year to $13.1 million; the trailing twelve-month figure through Jun 2026 stood at $13.1 million (down 2.57% YoY), and the FY2025 full-year result was $14.0 million, down 12.25% from the prior year.
• Operating Leases retreated to $13.1 million in Q2 2026 per TMCI's latest filing, from $13.6 million in the prior quarter.
• Across five years, Operating Leases topped out at $19.0 million in Q3 2022 and bottomed at $12.9 million in Q3 2025.
• Historically, Operating Leases has averaged $15.4 million across 5 years, with a median of $15.7 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Operating Leases climbed 4.65% in 2024, then decreased 21.57% in 2025.
• Over 5 years, Operating Leases stood at $15.5 million in 2022, then climbed by 2.27% to $15.9 million in 2023, then increased by 0.27% to $15.9 million in 2024, then fell by 12.25% to $14.0 million in 2025, then slipped by 6.37% to $13.1 million in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $13.1 million, $13.6 million, and $14.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.